Prescription Price Uncertainty Led Patients to Delay Care
Healthcare providers and pharmacies must address patient confusion as cost visibility remains a primary hurdle to treatment adherence.
Updated on Sept. 23, 2026 in Healthcare
Live Poll
Would you feel comfortable relying on manufacturer-provided assistance programs to help cover your prescription costs?
An August 2026 survey of 1,000 U.S. adults found that 35% of patients delayed or skipped prescriptions due to unknown costs. Nearly half of respondents reported that they do not know their medication expenses before arriving at the pharmacy counter.
Why it matters
Limited visibility into coverage and pricing decisions forces patients to act as their own financial stewards, often leading to reduced medication adherence. This operational friction highlights a significant disconnect between patient awareness and the complex pharmacy benefit ecosystem.
In a survey of 1,000 U.S. adults, 46% of respondents reached the pharmacy without knowing their costs, while 76% lacked understanding of the role pharmacy benefit managers play in their final out-of-pocket expenses.
The players
Model N
A Redwood City-based software company that provides revenue management solutions for life sciences and high-tech industries.
The details
Patients frequently attempt to manage these unknowns by using price-comparison apps or contacting pharmacies directly to verify costs. However, low awareness of manufacturer assistance programs—which only 19% of respondents have utilized—suggests a missed opportunity to mitigate these financial barriers. Many patients eventually influence their own costs by choosing cheaper alternatives or opting out of treatment entirely when confronted with unexpected prices.
Timeline
The consumer survey on prescription costs was conducted in August 2026.
Market Landscape
This survey reflects the ongoing patient engagement challenge regarding pharmacy benefit manager transparency, where complex billing structures create friction for consumers. It highlights a departure from traditional models where patients relied solely on provider and insurer guidance for cost management.
Operators in the pharmacy and clinical space should anticipate continued demand for price transparency tools and support services. Clarifying costs early in the patient journey is essential to improving adherence rates and maintaining clinic or pharmacy revenue flow.
The takeaway
The lack of cost visibility remains a primary driver for non-adherence, with patients often unaware of existing support mechanisms like manufacturer assistance. Businesses should prioritize clear, proactive communication of expected out-of-pocket costs at the point of care to stabilize demand.
Further reading
For more on industry shifts in patient access, visit Healthcare.
Source note: This article includes information reported by The Manila times.
Live Poll
Would you feel comfortable relying on manufacturer-provided assistance programs to help cover your prescription costs?
